BioSpace News Archive

Drug Development

GenSight’s RESCUE Trial Shows Positive Results for Rare Eye Disease

RESCUE and REVERSE are two separate but parallel Phase III trials evaluating the efficacy of a single intravitreal injection of GS0101 in patients with LHON from the G11778A mutation in the mitochondrial ND4 gene.

September 24, 2019
·
2 min read
·
Mark Terry
Career Advice

How to Properly Tailor Your Resume for the Job

Curious to know how you can tailor your resume? This blog post will give you some tips on tailoring your resume so it stands out from the rest of the pile!

September 24, 2019
·
3 min read
·
Laura Brothers
Deals

OncoCyte Acquires Razor Genomics to Improve Management of Early-Stage Lung Cancer

OncoCyte, a global oncology diagnostics company, recently announced that it will acquire Razor Genomics, which has developed a novel molecular diagnostic test for early-stage non-small cell lung cancer.

September 24, 2019
·
10 min read
·
Chelsea Weidman Burke
Bio NC

BioSpace Announces the 2019 Top 30 Life Sciences Ideal Employers

According to the second biennial 2019 Life Sciences Ideal Employer Report by BioSpace, the top three most important attributes cited by life sciences professionals around the world are the opportunity to do interesting and meaningful work, a competitive salary and health benefits.

September 24, 2019
·
1 min read
·
BioSpace Staff
Drug Development

Zealand’s Dasiglucagon Hits the Mark in Phase III Pediatric Hypoglycemia Trial

Shares of Zealand Pharma A/S are climbing in premarket trading after the company posted another late-stage success for dasiglucagon in treating severe hypoglycemia.

September 24, 2019
·
2 min read
·
Alex Keown
New Research: How Lung Cancer Develops Resistance to Chemotherapy

Researchers have now identified one pathway that lung cancer cells use to avoid chemotherapy, which may lead to new approaches for treatment.

September 24, 2019
·
2 min read
·
Mark Terry
Business

Bayer Funds New Joint Research Lab with $30 Million Over 5 Years

Bayer, Brigham and Women’s Hospital and Massachusetts General Hospital have launched a joint laboratory to research new drugs to treat chronic lung diseases.

September 24, 2019
·
3 min read
·
Mark Terry
IMBRUVICA Treats CLL and SLL Patients Without Chemotherapy

IMBRUVICA is a once-daily oral therapy, and describes itself as working differently than other treatments such as chemotherapy.

September 24, 2019
·
4 min read
·
Elizabeth Glasure
Biomagnet and CRISPR Combination Speed Drug Discovery, Research Shows

A team of researchers from the University of Toronto has combined CRISPR-based gene-editing technology with small biomagnetic devices to sort large populations of mixed cell types.

September 24, 2019
·
3 min read
·
Alex Keown
Biotech Bay

Roche AI Program Can Predict Progression of Diabetic Retinopathy

Researchers from Genentech and its parent company Roche have developed what is being called the first “deep learning model” that can predict which patients with diabetic retinopathy will progress the fastest.

September 24, 2019
·
3 min read
·
Alex Keown